KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageDebt RatioDebt to EquityEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginFCF Payout RatioGross MarginInventory AverageInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Invested CapitalReturn on Sales

Pfizer (PFE) Return on Equity (2016 - 2025)

Pfizer (PFE) has disclosed Return on Equity for 17 consecutive years, with 0.0% as the latest value for Q2 2025.

  • On a quarterly basis, Return on Equity changed 0.0% to 0.0% in Q2 2025 year-over-year; TTM through Jun 2025 was 0.0%, a 0.0% change, with the full-year FY2024 number at 0.0%, changed 0.0% from a year prior.
  • Return on Equity was 0.0% for Q2 2025 at Pfizer, up from 0.0% in the prior quarter.
  • In the past five years, Return on Equity ranged from a high of 0.01% in Q2 2021 to a low of 0.01% in Q4 2021.
  • A 5-year average of 0.0% and a median of 0.0% in 2022 define the central range for Return on Equity.
  • Peak YoY movement for Return on Equity: decreased -11bps in 2021, then rose 1bps in 2022.
  • Pfizer's Return on Equity stood at 0.01% in 2021, then skyrocketed by 101bps to 0.0% in 2022, then crashed by -404bps to 0.0% in 2023, then surged by 176bps to 0.0% in 2024, then surged by 120bps to 0.0% in 2025.
  • Per Business Quant, the three most recent readings for PFE's Return on Equity are 0.0% (Q2 2025), 0.0% (Q1 2025), and 0.0% (Q4 2024).